Telescope Innovations Corp. (CSE:TELI)

Canada flag Canada · Delayed Price · Currency is CAD
0.4100
+0.0300 (7.89%)
Jun 18, 2025, 12:54 PM EDT
-14.58%
Market Cap 22.00M
Revenue (ttm) 4.45M
Net Income (ttm) -2.05M
Shares Out 53.67M
EPS (ttm) -0.04
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 30,500
Average Volume 35,142
Open 0.4050
Previous Close 0.3800
Day's Range 0.4050 - 0.4100
52-Week Range 0.2300 - 0.6500
Beta 1.68
RSI 56.96
Earnings Date Jun 30, 2025

About Telescope Innovations

Telescope Innovations Corp., a chemical technology company, develops manufacturing processes and tools for the pharmaceutical and chemical industry in the United States and Canada. The company has a research collaboration with Pfizer Inc; and Standard Lithium Ltd. to develop a method for producing high-purity lithium sulfide. Telescope Innovations Corp. is based in Vancouver, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Henry Dubina
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol TELI
Full Company Profile

Financial Performance

In 2024, Telescope Innovations's revenue was 4.43 million, an increase of 56.80% compared to the previous year's 2.82 million. Losses were -1.32 million, 84.3% more than in 2023.

Financial Statements

News

There is no news available yet.